Metabolic Bone Disorder Completed Phase 4 Trials for Alendronic acid (DB00630)

Also known as: Metabolic Bone Disease / Bone Disease, Metabolic / Bone Diseases, Metabolic / Metabolic Bone Diseases / Metabolic bone disorders / Metabolic bone disease (disorder) / Bone metabolism disorder / Bone metabolism disorders

DBCOND0064775 (Metabolic Bone Disorder)Completed4 IdentifierTitlePurposeDrugs
NCT00157690Study of Alendronate to Prevent and Treat Osteoporosis in Cystic Fibrosis PatientsTreatment